表紙
市場調査レポート

動脈硬化症:世界の治験レビュー(2012年上半期)

Arteriosclerosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 228200
出版日 ページ情報 英文 134 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
動脈硬化症:世界の治験レビュー(2012年上半期) Arteriosclerosis Global Clinical Trials Review, H2, 2014
出版日: 2014年08月12日 ページ情報: 英文 134 Pages
概要

当レポートでは、動脈硬化症に関する臨床研究の最新動向について分析し、疾患の概要を初め、G7諸国・BRICS諸国・E7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 動脈硬化症
  • 当レポートの構成

各地域における治験

  • 各国の治験件数
    • アジア太平洋地域における治験件数の上位5カ国
    • 欧州における治験件数の上位5カ国
    • 北米における治験件数の上位国
    • 中東・北アフリカにおける治験件数の上位5カ国
    • 中南米における治験件数の上位5カ国

BRICS諸国における治験

G7諸国における治験

G7諸国における治験:進行状況別

E7諸国における治験

E7諸国における治験:進行状況別

フェーズ別の治験状況

  • 進行中の治験:フェーズ別

段階別の治験状況

未達成の治験

一定期間に採用された被験者

有望なスポンサー

  • 動脈硬化症の治験に参加している上位企業

有望な薬剤の比較分析

治験のプロファイル

  • 上位企業の治験の概要
    • Merck & Co., Inc
    • GlaxoSmithKline plc
    • AstraZeneca PLC
    • Abbott Laboratories
    • Pfizer Inc.
    • Sanofi
    • Boston Scientific Corporation
    • Novartis AG
    • Medtronic, Inc.
    • Bristol-Myers Squibb Company
    • 第一三共
    • Eli Lilly and Company
    • Cordis Corporation
    • F. Hoffmann-La Roche Ltd.
    • InfraReDx, Inc.
    • TCA Cellular Therapy, LLC
    • Johnson & Johnson
    • Boehringer Ingelheim GmbH
    • Guerbet Group
  • 上位大学・研究機関・病院の治験の概要
    • KOREA UNIVERSITY
    • Brigham and Women's Hospital
    • Johns Hopkins University
    • Maastricht University Medical Center
    • Radboud University
    • Copenhagen University Hospital at Herlev
    • Mayo Clinic
    • University of Wisconsin Madison
    • Assistance Publique - Hopitaux de Paris
    • University of California, San Francisco
    • Emory University
    • The Ohio State University
    • Odense University Hospital
    • University of Sao Paulo
    • The National Institute of Allergy and Infectious Diseases
    • 久留米大学
    • Seoul National University Bundang Hospital
    • Vanderbilt University
    • Beth Israel Deaconess Medical Center
    • Hadassah Medical Organization

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arteriosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Arteriosclerosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Arteriosclerosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Arteriosclerosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Arteriosclerosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Arteriosclerosis Therapeutics Clinical Trials
  • Prominent Drugs
    • Clinical Trial Profiles
      • Clinical Trial Overview of Top Companies
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Korea University
      • Clinical Trial Overview of Korea University
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • National Institute on Aging
      • Clinical Trial Overview of National Institute on Aging
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • National Defense Medical College
      • Clinical Trial Overview of National Defense Medical College
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Arteriosclerosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Arteriosclerosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Arteriosclerosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Defense Medical College, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*

List of Figures

  • Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top